Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up.

Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C Virus Infection Blood-Borne Infections Communicable Diseases Digestive System Diseases Flaviviridae Infections Hepatitis Hepatitis C Hepatitis, Viral, Human Infections Liver Diseases RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Brussel

Brussels, 1090, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
≥18 years

Exclusion criteria

Positive HCV serology with negative HCV RNA
Previously eradicated patients in UZ Brussel

Treatment and study plan

Contact the patient

Other

Phone call, email or letter to contact the patient to relink them.

Primary outcomes

Retrospective data collection

Time frame: before contacting the patient

Prevalence of diagnosed but untreated HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.
Prospective interventional study

Time frame: from first contact of the patient till 12 weeks after end of treatment.

To recall DBU patients by phone, e-mail or letter, trying to optimize treated and cured patients after recall

Secondary outcomes

Reason lost in follow-up

Time frame: from first contact of the patient till 12 weeks after end of treatment.
Understanding the different reasons why patients were lost in follow-up with the aim of improving our hospital quality in the future:
- Unaware of positive hep C serology
- Follow-up or treatment in other centre
- Refusal of previously proposed therapy
- Other?

Sponsors and collaborators

Lead sponsor

Universitair Ziekenhuis Brussel

Other

Registry information

Acronym: Relink

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Aug 3, 2023
Registry last updated: Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed